Medtronic (MDT) Long-Term Debt Issuances (2015 - 2025)

Medtronic (MDT) posted Long-Term Debt Issuances of $1.7 billion for Q4 2025, down 45.56% sequentially from $3.2 billion in Q3 2024.

Medtronic (MDT) Long-Term Debt Issuances (2015 - 2025) Analysis & Trends

Medtronic has reported Long-Term Debt Issuances for 9 years, with the latest figure at $1.7 billion in Q4 2025.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $1.7 billion in Q4 2025, while the trailing twelve-month figure through Apr 2026 was $1.7 billion (down 45.56% YoY) and the FY2026 annual result came in at $1.7 billion, down 45.56% from the prior year.
Long-Term Debt Issuances declined to $1.7 billion in Q4 2025 per MDT's latest filing, from $3.2 billion in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $3.2 billion in Q3 2024 and troughed at $1.7 billion in Q4 2025.
A 3-year average of $2.3 billion and a median of $2.0 billion in 2023 frame the typical range for Long-Term Debt Issuances.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-33.00 Mn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	-
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	-
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	-
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	109.26 Mn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	-
10	Zimmer Biomet Holdings	19.42 Bn	19.01 Bn	1.54 Bn	-

Download Data